CDKN2A and cancer: Indeed, the observation that the large majority of cancer-associated mutations targeting CDKN2A are mainly affecting the p16 open reading frame, reinforces the importance of p16 as a regulator of cellular physiology and stresses the necessity to further investigate p16-mediated regulatory processes.